Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
1982-1-28
pubmed:abstractText
Heparin fractions of different molecular weight and with high affinity for antithrombin were studied with respect to their ability to potentiate the inhibition of activated clotting factors by antithrombin. Inhibition of thrombin, Factor IXa and Factor XIa showed similarities in the dependence on the molecular weight of heparin and was found to decrease with decreasing molecular weight. Inactivation of Factor Xa, Factor XIIa and kallikrein was, however, less dependent on the size of the polysaccharide and, to a great extent, was potentiated even by low-molecular-weight heparin fractions that had virtually no effect on the inhibition of thrombin, Factor IXa and Factor XIa.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/6914196-1000525, http://linkedlifedata.com/resource/pubmed/commentcorrection/6914196-1006626, http://linkedlifedata.com/resource/pubmed/commentcorrection/6914196-1087054, http://linkedlifedata.com/resource/pubmed/commentcorrection/6914196-1180962, http://linkedlifedata.com/resource/pubmed/commentcorrection/6914196-1247523, http://linkedlifedata.com/resource/pubmed/commentcorrection/6914196-1267803, http://linkedlifedata.com/resource/pubmed/commentcorrection/6914196-1278445, http://linkedlifedata.com/resource/pubmed/commentcorrection/6914196-13971270, http://linkedlifedata.com/resource/pubmed/commentcorrection/6914196-226960, http://linkedlifedata.com/resource/pubmed/commentcorrection/6914196-286307, http://linkedlifedata.com/resource/pubmed/commentcorrection/6914196-4473201, http://linkedlifedata.com/resource/pubmed/commentcorrection/6914196-4586320, http://linkedlifedata.com/resource/pubmed/commentcorrection/6914196-4674072, http://linkedlifedata.com/resource/pubmed/commentcorrection/6914196-4796921, http://linkedlifedata.com/resource/pubmed/commentcorrection/6914196-486155, http://linkedlifedata.com/resource/pubmed/commentcorrection/6914196-494159, http://linkedlifedata.com/resource/pubmed/commentcorrection/6914196-5578915, http://linkedlifedata.com/resource/pubmed/commentcorrection/6914196-5731932, http://linkedlifedata.com/resource/pubmed/commentcorrection/6914196-61631, http://linkedlifedata.com/resource/pubmed/commentcorrection/6914196-61963, http://linkedlifedata.com/resource/pubmed/commentcorrection/6914196-659613, http://linkedlifedata.com/resource/pubmed/commentcorrection/6914196-694829, http://linkedlifedata.com/resource/pubmed/commentcorrection/6914196-743219, http://linkedlifedata.com/resource/pubmed/commentcorrection/6914196-992045
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0264-6021
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
193
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
395-400
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1981
pubmed:articleTitle
The molecular-weight dependence of the rate-enhancing effect of heparin on the inhibition of thrombin, factor Xa, factor IXa, factor XIa, factor XIIa and kallikrein by antithrombin.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S.